a multicentre, randomised, double blind, placebo controlled phase ii study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid ar..
assessing competencies in rheumatology
assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis
capability for daily activities in old people with rheumatoid arthritis: a population based study
case number 32: thiemann’s disease
chondroprotective activity of n-acetylglucosamine in rabbits with experimental osteoarthritis
circulating leptin levels in juvenile idiopathic arthritis: a marker of nutritional status?
contribution of polymorphisms in the apolipoprotein ai-ciii-aiv cluster to hyperlipidaemia in patients with gout
defining hip pain for population studies
estimated prediagnosis radiological progression: an important tool for studying the effects of early disease modifying antirheumatic drug treatment in rheumatoid ar..
evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state
evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement
first line treatment of knee osteoarthritis in outpatients in france: adherence to the eular 2000 recommendations and factors influencing adherence
incidence and prevalence of complaints of the neck and upper extremity in general practice
intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate
is rheumatoid arthritis disappearing?
livedo reticularis and pregnancy morbidity in patients negative for antiphospholipid antibodies
low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in ra synovium
lupus erythematosus with leflunomide: induction or reactivation?
pain and joint mobility explain individual subdimensions of the health assessment questionnaire (haq) disability index in patients with rheumatoid arthritis
patient centred outcomes in osteoarthritis
predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study
prevalence and predictors of fragility fractures in systemic lupus erythematosus
prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data
prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary sj?gren’s syndrome
six months open label trial of leflunomide in active ankylosing spondylitis
standardised work-up programme for fever of unknown origin and contribution of magnetic resonance imaging for the diagnosis of hidden systemic vasculitis
teleradiotherapy of joints in rheumatoid arthritis: lack of efficacy
up regulated expression of fractalkine/cx3cl1 and cx3cr1 in patients with systemic sclerosis
using patients’ and rheumatologists’ opinions to specify a short form of the womac function subscale
validation and patient acceptance of a computer touch screen version of the womac 3.1 osteoarthritis index